These results suggest that early MYC activation triggered PD-L1 expression in MM cells to evade cytotoxic CD8+ T cell surveillance via PD-1 blockade, thereby explaining the selective efficacy of PD-1 inhibition in this model of early progression. Here, PDCD1 is linked to Miyoshi myopathy.